ID Week

Results indicate patients who received single-dose oritavancin were significantly less likely to be hospitalized, compared to those who received multidose vancomycin.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Instead, increasing duration of postoperative antimicrobial prophylaxis is associated with higher odds of acute kidney injury and C diff infection in a dose-dependent manner.

Study results indicate that clinicians start prescribing new drugs off-label almost as soon as the drugs become available.

First large-scale study on trends in invasive candidiasis finds species distribution of isolates varied between blood and nonblood sterile sites.

Delafloxacin was found to be relatively safe and well tolerated in patients with acute bacterial skin and skin structure infections with past or present cardiac or vascular difficulties.

A new analysis details the substantial burden of candidemia in the United States and calls for ongoing surveillance efforts to help assess the impact of prevention interventions.

Over one-third of patients with invasive aspergillosis lacked a documented immunosuppressive condition.

George Thompson, MD, principal investigator of the STRIVE study discusses optimal dosing for rezafungin in treating candidemia and/or invasive candidiasis.

Researcher give insight into the importance of antibiograms in outpatient management of urinary tract infections

New research finds patients with carbapenem-resistant bloodstream infections have a lower likelihood of surviving hospitalization or being discharged home.

Mary Choi, MD, MPH, discusses the progress made in treating and preventing Ebola and the challenges of fighting the community resistance of the Congolese.

Nonadherence to antiretroviral therapy was associated with a higher risk of death.

A look into the challenges of including infection preventionists in antimicrobial stewardship programs.

The results of a new study suggest the approach can help stratify patients with the disease.

The Contagion® editorial staff will be providing exclusive written and video coverage from ID Week 2018.

A testing stewardship effort found that using a “hard stop” alert system may help reduce inappropriate C. difficile testing.

James S. Lewis, PharmD, FIDSA, explains how pharmacists can advocate for judicious antibiotic use in patients through educating the patients themselves, as well as providers.

James S. Lewis, PharmD, FIDSA, explains why addressing issues surrounding antibiotic use in veterinary medicine is crucial in the fight against antibiotic resistance.

In case you missed them, we've compiled the top 5 articles from this past week.

At ID Week 2017, Dr. Laura Cooley, CDC, discussed the increasing number of Legionnaires’ cases in the United States, underscoring the need for stronger water management practices.

Brinda Emu, MD, offers insight into the HIV monoclonal antibody ibalizumab.

Dr. Shibani Mukerji discusses how HIV affects the brain as part of a symposium at ID Week 2017.

Michael N. Dudley, PharmD, explains how VABOMERE was associated with a higher overall cure rate and lower mortality compared with the best available therapy in patients with CRE infections in a recent trial.

Monica Mahoney, PharmD, BCPS-AQ ID, explains the first-line empiric therapy for candidemia.

Ciara Kennedy, PhD, breaks down APX001, a new antifungal with a unique mechanism of action.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Dr. Daniel Lucey provided insight on past and current yellow fever outbreaks and vaccine shortages at ID Week 2017; he also cited the very real possibility of yellow fever hitting Asia.

Amanda Paschke, MD, MSCE, explains the advantage of administering a beta-lactam in combination with a beta-lactamase inhibitor.

Results from a randomized, double-blind, placebo-controlled trial show that letermovir protects from viral infection in CMV-seropositive individuals following allogeneic hematopoietic cell transplantation.